Impact of post-brentuximab vedotin consolidation on relapsed/refractory CD30+ Hodgkin lymphomas: a large retrospective study on 240 patients enrolled in the French Named-Patient Program.

Perrot, Aurore; Monjanel, Hélène; Bouabdallah, Réda; Quittet, Philippe; Sarkozy, Clémentine; Bernard, Marc; Stamatoullas, Aspasia; Borel, Cécile; Bouabdallah, Krimo; Nicolas-Virelizier, Emmanuelle; Fournier, Marion; Morschhauser, Franck; Brice, Pauline.
Haematologica; 101(4): 466-73, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26768687